BRYCE RICHARD PAUL 4
4 · PUMA BIOTECHNOLOGY, INC. · Filed Feb 13, 2020
Insider Transaction Report
Form 4
BRYCE RICHARD PAUL
SR VP, CLINICAL RESEARCH & DEV
Transactions
- Award
COMMON STOCK
2020-02-11+43,274→ 78,108 total - Award
STOCK OPTION (RIGHT TO BUY)
2020-02-11+54,842→ 54,842 totalExercise: $12.34Exp: 2030-02-10→ COMMON STOCK (54,842 underlying)
Footnotes (2)
- [F1]Represents Restricted Stock Units which vest (i) with respect to one-third (1/3rd) of the shares subject thereto on the first anniversary of the vesting commencement date of January 1, 2020 ("Vesting Commencement Date") and (ii) with respect to 1/36th of the shares subject thereto on each monthly anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.
- [F2]The vesting commencement date ("Option Vesting Commencement Date") of the option is January 1, 2020. The option vests (i) with respect to one-third (1/3rd) of the shares underlying the option on the first anniversary of the Option Vesting Commencement Date and (ii) with respect to 1/36th of the shares underlying the option on each monthly anniversary of the Option Vesting Commencement Date thereafter, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.